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Abstract 
Sarcomas are rare heterogenous malignancies of mesenchymal origin characterised by complex karyotypes 
but no specific abnormalities.  Recurrence is common and metastatic disease carries poor survival despite 
standard DNA-damaging radiotherapy or chemotherapy.  DNA double strand breaks (DSB) are either 
repaired by mechanisms such as homologous recombination (HR); or result in cell death by apoptosis.  
Endogenous γH2AX and SCE formation are early and late events, respectively and their levels are 
considered surrogate measures of genomic instability.   
Combined γH2AX and SCE analysis were used to evaluate endogenous DNA DSB levels (and their 
subsequent repair) in 9 primary sarcoma cell lines and compared with well-established commercial lines.  All 
the sarcoma cell lines had elevated γH2AX and SCE levels, but there was no correlation between the DNA 
DSB frequency and subsequent SCE.  Typically radio-resistant osteosarcoma cells had relatively low γH2AX 
frequency, but high SCE counts suggestive of efficient DNA repair.  Conversely, liposarcoma cells derived 
from a radio-sensitive tumour had high H2AX but relatively lower SCE levels that may imply inefficient DNA 
DSB repair. 
To our knowledge, this is the first report that correlates H2AX and SCE levels in primary sarcoma cell lines 
and may provide insight into potential response to DNA damaging-treatments. 
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Introduction 
Soft tissue sarcomas (STS) are group of rare, heterogeneous malignancies of mesenchymal origin that 
affect around 2300 people a year in the UK [1].  They comprise less than 1% of all cancer diagnoses among 
adults but pose a significant diagnostic challenge with over 22 different subtypes and over 100 distinct 
morphologies (ICD-10) [2].   Current treatment recommendations for localised disease mainly involve a 
combination of surgery and radiotherapy in most subtypes, with chemotherapy reserved for a few sensitive 
subtypes [3, 4].   Overall survival for localised disease is in the order of 50-60% at 5 years but with metastatic 
disease, two-year survival is only 20 - 30% with a median survival of around 12 months with standard 
chemotherapy [5].   
STS fall into one of two large genomic classes.  The first are characterised by known, specific abnormalities 
such as chromosomal translocations or gene mutations and comprise around 20% of STS.  The majority of 
sarcomas on the other hand are characterised by complex seemingly-random DNA copy number aberrations 
across the entire genome.  They have no known specific abnormalities (a notable exception are well-
differentiated liposarcomas that frequently carry chromosome 12q amplification) and their complex 
karyotypes are believed to be the result of genomic instability, a hallmark of the cancer phenotype [6]. 
Sister chromatid exchange (SCE) analysis is a method that allows the physical quantification of exchanged 
genetic material between sister chromatids during in vitro mitosis.  Considered an endpoint of DNA repair by 
homologous recombination, measurement of SCE is a well-established and sensitive method for detecting 
DNA damage in the form of double strand breaks (DSB) induced by genotoxic agents [7, 8].   The current 
method for SCE analysis developed by Perry and Wolff uses the thymidine substitute, 5’-Bromo-2’-
deoxyuridine (BrdU), which is incorporated into the DNA over two consecutive cell cycles creating an 
imbalance in the amount of BrdU in each sister chromatid [9].  Once stained, a harlequin banding pattern can 
be observed and exchange of genetic material can be visualised seen as a mismatch between dark and 
lighter chromatids (Figure 1).  The frequency of SCE can thus be enumerated in metaphase chromosome 
spreads prepared from cells toward the end of the second mitosis following BrdU treatment.   
An even earlier event in the DNA DSB repair process is the phosphorylation of the histone molecule, H2AX 
at serine-139 to γH2AX which accumulates at the sites of damage and recruits other DNA repair proteins.  
Phosphorylation of the histone protein H2AX is well-recognised as an early step in the cellular recognition of 
DNA DSB for subsequent repair [10].  Using phospho-specific antibodies, γH2AX foci at sites of DNA 
damage can be visualised and enumerated as another measure of DNA repair in eukaryotic cells [11].  
Spontaneous SCE and γH2AX formation has been observed in human cells where they are believed to be 
the result of endogenous DNA damage that causes collapsed replication forks and DNA double stand breaks 
(DSBs) during mitosis.  The frequency of endogenous DNA DSB repair has therefore been widely used as a 
surrogate measure of genomic instability in these cells [12, 13].    
Unlike γH2AX analysis which is done on interphase chromosomes, the specific timing requirement of 
metaphase spread preparation for SCE analysis makes this method technically challenging and the majority 
of published studies utilising SCE analysis have focused on peripheral blood lymphocytes, which have 
relatively predictable doubling time.   The observed frequency of endogenous SCE in normal human tissue 
and peripheral blood lymphocytes (PBL) is around 6 - 8 per cell [14, 15].  Elevated frequency of SCE has 
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been observed in PBL of patients with breast, prostate, gastric, ovarian and cervical cancers showing up to 
three times the normal SCE frequency [12].  Individuals with Blooms syndrome, a familial cancer-
predisposing disease also have remarkably high SCE frequency in their PBLs with an average of 89 per 
diploid cell [16].  Subsequent studies exploring the association between elevated PBL SCE frequency and 
cancer however showed mixed results and suggested a generalised increase in genetic instability but no 
specific links to tumour initiation or biomarker development [17-20].   
SCE data on cancer cells is derived largely from haematologic malignancies such as leukaemia where 
tumour cells are prominent in the circulation [21] while only a handful of studies have been published based 
on established and commercially available solid organ tumour cell lines [12, 22, 23].  With the exception of 
uveal melanomas [12], these have all shown that tumour cells possess elevated SCE frequency in keeping 
with genetic instability as a hallmark of cancer.  There is unfortunately poor representation of STS among 
commercially-available cell lines with the majority being translocation-driven subtypes.  Further, the 
limitations of commercial cell lines as an in vitro disease model is increasingly being recognised.  Cellular 
adaptation with prolonged culture in artificial conditions, as well as a lack of cellular heterogeneity that is 
characteristic of in vivo tumours are important factors that are believed to account for poor correlation of 
tumour cell line response with clinical outcomes.  To ameliorate these important limitations, a widely 
accepted alternative to commercial cell lines are those directly derived from tumours (primary tumour cells) in 
early culture with less adaptation to artificial conditions.  Ethical and logistic constraints associated with 
obtaining fresh tumour tissue (typically within minutes of surgery or biopsy), variable rates of successful 
establishment in culture and unpredictable subsequent in vitro behaviour makes it rather challenging to 
utilise them for research in general and SCE analysis in particular.      
In this study, we assessed endogenous genomic DNA damage/repair in a cohort of primary STS cell lines 
representing a range of subtypes.   The frequency of early and late endogenous DNA DSB repair were 
measured using γH2AX and SCE respectively, as surrogates for genomic instability and compared to those 
observed in long-established, commercially-available sarcoma cell lines, low SCE tumour cells and non-
tumour cells.   
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Materials and Methods 
Cell lines and Cultures 
Primary STS cell lines were developed from patient samples collected at the Royal Hallamshire Hospital, 
Sheffield as previously described [24].  Informed consent was obtained from each patient after ethical 
approval, (Reference number 09/H1313/52) and tissue samples were handled in accordance with research 
ethics guidelines and the Human Tissue Act 2004.  Short Tandem Repeat (STR) profiling was used to 
confirm the identity of all cell lines included in this study [24].  Sarcoma cell lines, SOM196b and h-TERT-
RPE-1 cells were maintained in culture as previously described [12, 24] and sub-cultured as required.   
Sister Chromatid Exchange Analysis 
SCE analysis was performed as previously described [12].  Cell cultures were incubated with 0.24 µM 5’-
Bromo-2’-deoxyuridine (BrdU) for approximately two cell cycles.  This duration varied between 3 and 7 days 
depending on the proliferation rate of the cells and multiple attempts were required to identify the required 
duration, particularly for the primary cell lines.  Cell cycling was arrested in metaphase with 2 to 4-hour 
incubation of 10µg/ml colcemid (ThermoFisher Scientific®; Paisley, UK).  Chromosomes were then harvested 
by trypsinisation, centrifuging and re-suspending in 0.075M potassium chloride (KCl) at 37˚C for 40 minutes 
before fixing in a 3:1 methanol to acetic acid solution.  Metaphases chromosome spreads were prepared on 
cold wet slides before staining with an adapted Perry and Wolff method with incubation in Hoescht 33258 
dye for 15 minutes and UV-light exposure for 12 minutes.  Stained metaphases were visualised with a BH-2 
light microscope and images captured with a Cohu® high performance CCD camera (Cohu Electronics; San 
Diego CA, USA) and Powergene® software (Applied Imaging Santa Clara, CA, USA).   The number of 
chromosomes and exchanges in each metaphase spread was recorded.  Chromosomes that were clearly 
overlapping or twisted were excluded from the exchange count, as is consistent with previous reports.   
SCE counts were performed on up to 30 harlequin-stained metaphase chromosome spreads (Figure 1), 
where available.  Due to technical difficulties with the harlequin-staining technique however, it was not 
always possible to obtain a sufficient number of metaphase chromosome spreads from a single culture and 
chromosome harvest.  In these cases, SCE analysis was repeated at a subsequent culture passage in order 
to obtain sufficient numbers (Table 1).  For primary sarcoma cell lines, a minimum of ten analysed 
metaphase spreads was required for inclusion in this study.   
γH2AX assay  
Analysis of γH2AX foci formation was again performed as previously described [12].  Viable cells were 
seeded at a density of 20,000 each on glass coverslips placed in six-well plates and cultured overnight.  The 
cells were then washed with ice cold phosphate-buffered saline (PBS) before fixing with 3% 
paraformaldehyde.  They were then rinsed with PBS and permeablised with 0.2% Triton-X for 5 minutes 
before blocking with 10% goat serum for 1 hour.  Following another brief wash with PBS, the cells were 
incubated at 4°C overnight in the dark with Cy3-conjugated rabbit anti-γH2AX antibody (Cell Signaling 
Technologies®; Danvers MA, USA) diluted 1:500 in 10% goat serum in PBS.  Cells were subsequently 
washed on a shaker with PBS and the coverslips inverted onto microscope slides and mounted with 
Vectashield containing DAPI (Vector®; Peterborough UK).  Slides were stored in the dark at 4˚C and the 
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number of foci per nucleus in 100 cells were counted on a UV spectrum-red fluorescent Nikon image 
analysis microscope at 100x magnification.     
Results 
Endogenous SCE Levels in Sarcoma Cell Lines 
Nine primary cell lines, representing four soft tissue sarcoma subtypes were analysed for SCE (Table 1).  
Two of these are morphologically-distinct cultures that represent separate tumour cell clones (variants) 
derived from a single leiomyosarcoma, as we have previously demonstrated [24].   Four established and 
commercially-available sarcoma cell lines U-2 OS, SK-LMS-1, SK-UT-1 and SW-1353, all of which are 
known to have complex karyotypes and high levels of endogenous SCE [12] were analysed as high-SCE 
controls.  A non-tumour cell line, hTERT-RPE-1 and a uveal melanoma cell line SOM-196b, previously 
shown to possess low SCE levels [12] were used as normal and low SCE controls, respectively.  
 
  
Figure 1: Endogenous sister chromatid exchanges and γH2AX foci in sarcoma cells. 
A - Harlequin-stained metaphase chromosomes from a Shef-DDLPS 02 (de-differentiated liposarcoma) cell showing a 
hyper diploid karyotype with over 120 chromosomes. B. Higher magnification of a section of the same metaphase 
chromosome spread showing nine sister chromatid exchanges (red arrows).  C. Interphase nuclei of hTERT-RPE1 
(human retinal epithelium) cells showing <10 endogenous γH2AX foci each (red dots).  D.  Shef-DDLPS 02 cell 
nucleus showing >10 γH2AX foci (red dots). 
Metaphase chromosomes were stained with stained with Hoescht 33258 dye followed by exposure to UV light.  Interphase nuclei 
were stained using Cy3-conjugated rabbit anti-γH2AX antibody and counterstained blue with DAPI.   
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Tumour cells were frequently hyper-diploid with significant inter- and intra-tumour heterogeneity in terms of 
chromosome number (Figure 1; Table 1).  To account for this heterogeneity and facilitate accurate 
comparison with normal diploid cells, the number of exchanges visualised per metaphase spread was 
normalised for a diploid (2n) karyotype by multiplying observed SCE by 46, then dividing by observed 
chromosome number. 
Table 1:  Endogenous Sister Chromatid Exchange in Sarcoma Cell Lines 
Cell Line Histological Subtype 
Passage 
Number 
No of 
metaphases 
Chromosome count 
Median (range) 
Median SCE Count 
Range 
Observed aNormalised 
Non-tumour/Low SCE controls 
hTERT-RPE 1 Normal Retinal Epithelium  7 43 (31 – 48) 8 8 6 - 13 
SOM-196b Uveal Melanoma  11 45 (34 - 46) 6 6 1 - 14 
Commercially-available Sarcoma Cell Lines 
U-2 OS Osteosarcoma  30 71 (64 - 76) 47 31 17 - 63 
SK-LMS1 Leiomyosarcoma  10 100 (86 - 151) 42 18 14 - 37 
SK-UT1 Uterine leiomyosarcoma  20 44 (32 - 48) 14 15 8 - 31 
SW-1353 Chondrosarcoma  12 48 (45 - 53) 17 16 9 - 20 
Primary Sarcoma Cell Lines 
Shef-UPS 01 Undifferentiated Pleomorphic Sarcoma p69 22 59 (44 – 67) 13 10 7 - 18 
bShef-UPS 02 Undifferentiated Pleomorphic Sarcoma 
p15 10 60 (56 – 60) 23 17 10 - 27 
p30 7 89 (53 – 114) 24 16 7 - 30 
bShef-UPS 03 Undifferentiated Pleomorphic Sarcoma 
p17 29 56 (47 – 60) 23 18 9 - 33 
p33 24 71 (50 – 126) 23 17 9 - 32 
bShef-UPS 04 Undifferentiated Pleomorphic Sarcoma 
p3 12 60 (51 – 65) 20 16 8 - 25 
p8 30 59 (52 – 69) 20 15 7 - 30 
Shef-DDLPS 01 Dedifferentiated liposarcoma p70 29 76 (41 – 97) 22 13 7 - 21 
b, cShef-DDLPS 02 Dedifferentiated liposarcoma 
p12 30 108 (51 – 154) 35 14 9 - 25 
p23 29 117 (52 – 151) 33 13 7 - 26 
Shef-LMS 01 w1 Leiomyosarcoma p51 25 127 (74 - 152) 28 10 8 - 20 
Shef-LMS 01 ws Leiomyosarcoma p62 22 118 (80 - 134) 31 11 7 - 21 
Shef-MFS 02  Myxofibrosarcoma p2 15 77 (42 - 105) 24 15 11 - 26 
a Normalised for 2n karyotype by multiplying observed SCE counts by 46, then dividing by observed chromosome number 
b Tumour was previously treated with radiotherapy prior to resection 
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c SCE analysis was repeated after further in vitro culture  
Elevated Endogenous SCE Levels in Primary Sarcoma Cell Lines 
The control cell lines, SOM- 196b and hTERT-RPE1 cell lines had median SCE counts of 6 and 8 per diploid 
(2n) metaphase spread, respectively as expected (Figure 2).  Certain factors are known to potentially 
confound the results of endogenous SCE analysis in cultured cells.  For example, BrdU that is used to 
substitute thymidine residues in DNA and required for harlequin staining pattern of sister chromatids for 
analysis is known to be genotoxic and can result in slightly increased SCE frequency of around 1 – 3 per 
metaphase [25-27]. Furthermore, it has been demonstrated that certain media supplements (such as 
antibiotics or serum) can induce SCE in cultured cells in vitro [28, 29].  In order to minimise these effects, the 
lowest BrdU concentration (0.24M) that produced satisfactory banding was used in all experiments [12] and 
normal cell line controls were cultured using identical media and supplements as the primary sarcoma cells 
prior to SCE analysis.  The normal control cell line demonstrated SCE level that was within the expected 
range of 6 – 8 per metaphase spread suggesting that these potential artefacts if present, had minimal effect 
on our results.  
 
  
  
Figure 2:  Frequency of Sister Chromatid Exchange (SCE) in Sarcoma Cell Lines 
Normal and low SCE controls (clear boxes) had SCE frequency within the expected normal range (6 - 8 per 2n cell).  
All the sarcoma cell lines show SCE frequency above the normal range with primary sarcoma cells (dark grey boxes) 
comparable to established commercially-available sarcoma cells (light grey boxes).  
SCE counts were normalised for diploid (2n) karyotype by multiplying the number of observed SCE by 46, then 
dividing by observed chromosome number.  Boxes represent interquartile range with horizontal line at median; while 
whiskers represent the minimum and maximum enumerated SCEs derived from 10 - 30 metaphase chromosome 
spreads.  
hT
ER
T R
PE
-1
SO
M-
19
6B
U-
2 O
S
SK
-LM
S1
SK
-U
T1
 
SW
-13
53
 
Sh
ef-
UP
S 0
1
Sh
ef-
UP
S 0
2
Sh
ef-
UP
S 0
3
Sh
ef-
UP
S 0
4
Sh
ef-
DD
LP
S 0
1
Sh
ef-
DD
LP
S 0
2
Sh
ef-
LM
S 0
1 w
1
Sh
ef-
LM
S 0
1 w
s
Sh
ef-
MF
S 0
2
0
10
20
30
40
50
60
70
Median SCE 
  7 
All four commercially-available sarcoma cell lines had endogenous SCE levels that were well above the 
expected normal range of 6 - 8, with median SCE counts of 15 - 31 per 2n metaphase spread (Table 1).  
Among these, it was notable that the osteosarcoma cell line, U2-OS had SCE levels (31 per 2n metaphase 
spread) that were nearly double those seen among the other sarcoma cell lines (Figure 2).  SCE levels 
observed in the primary sarcoma cell lines were similar to those of the commercial lines.  All nine primary 
sarcoma cell lines had SCE levels that were higher than the normal range with at least 7 endogenous SCEs 
seen within each metaphase chromosome spread and median SCE counts of between 10 and 18 per 2n 
metaphase spread.  The elevated SCE levels were independent of chromosome number and STS subtype 
(Table 1; Figure 2). 
In the four primary sarcoma cell lines where SCE analysis was repeated after approximately 4 months, the 
additional 5 to 15 culture passages did not appear to significantly affect the SCE levels.  Furthermore, it was 
interesting to note that in Shef-UPS 02 and Shef-UPS 03, despite an increase in the median and range of 
the chromosome numbers observed between the two time-points, their SCE frequency remained at about 
the same level when normalized for a diploid karyotype (Table 1). 
 
Endogenous γH2AX foci are increased in Sarcoma cells, but do not correlate with 
SCE levels 
Detection of phosphorylated H2AX (γH2AX) foci by immunofluorescence was used for the detection of 
endogenous DNA double strand break (DSBs).   We performed γH2AX analysis on eight primary STS cell 
lines.  The osteosarcoma (U-2 OS) and retinal epithelial (hTERT-RPE1) cell lines were used as tumour and 
non-tumour cell line controls, respectively.  The results were correlated with the corresponding endogenous 
SCE levels and are summarised in Figure 3. 
The normal cell line, hTERT-RPE1 showed very little evidence of endogenous DNA DSB with no cells 
showing more than 10 γH2AX foci.  Among all the sarcoma cell lines however, at least 10% of cells showed 
more than 10 γH2AX foci.   There was no relationship between the SCE levels and frequency of γH2AX foci 
among the sarcoma cell lines (Spearman’s r2 = 0.029; p = 0.99).  U-2 OS, the osteosarcoma cell line that 
had almost double the number of SCEs seen among the other sarcoma cell lines surprisingly had relatively 
few γH2AX foci (Figure 3).    Conversely, the highest frequency of γH2AX foci (> 65% of cells showing >10 
foci) was observed in dedifferentiated liposarcoma cell lines Shef-DDLPS 01 and Shef-DDLPS 02 whose 
SCE levels were only moderately elevated with medians of 13 and 14 per 2n metaphase spread, 
respectively (Table 1; Figure 2).  Interestingly, one of these two cell lines was derived from a de-
differentiated liposarcoma that prior to excision, was treated with radiotherapy to which the patient had a 
significant radiologic and histologic response [24].  Another notable observation was the more than three-fold 
difference in the frequency of cells showing >10 γH2AX foci between w1 and ws variants of Shef-LMS 01, 
which had very similar SCE levels (Figure 3). 
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Figure 3:  Endogenous γH2AX foci and Sister Chromatid Exchange Analysis in Sarcoma Cell Lines 
No relationship was seen between the frequency of endogenous γH2AX foci (bars) and SCE (corresponding black 
dots) among sarcoma cells lines (Spearman’s r2 = 0.029; p = 0.99)   All nine cell lines however showed high frequency 
of endogenous γH2AX foci and SCE, compared with non-tumour control hTERT-RPE1 cells that had no cells with 
more than 10 endogenous γH2AX foci.    
Bars plotted along the left y-axis represent the percentage of 100 randomly-selected cells in each corresponding cell 
line with >10 endogenous γH2AX foci and data is shown as the mean of 3 independent repeat experiments.  Black 
dots plotted along the right y-axis represent the median SCE counts from 10 - 30 metaphase chromosome spreads.  
The SCE counts were normalised for a diploid (2n) karyotype by multiplying the number of observed SCE by 46, then 
dividing by observed chromosome number.    
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Discussion 
Reports of SCE analysis performed directly on solid tumour cells are rare in published literature.   Precise 
timing of BrdU exposure and chromosome harvest is largely unpredictable in many solid tumour cell lines, 
but especially so among primary cell cultures, such as those used in this study.  To our knowledge, this is 
the first report of combined SCE and γH2AX analysis for the measurement of genomic instability in sarcoma 
cells.   
The nine primary tumour cell lines in this study have previously been shown to possess very complex 
karyotypes [24].  It was therefore not surprising that the endogenous SCE levels observed were consistently 
higher than the normal range even after correction for aneuploidy (Table 1; Figure 2).   Given the magnitude 
of genomic perturbation that is pervasive among these tumours, it was expected that the SCE frequencies 
would be even higher than those observed.  When compared with other cancers however, these results are 
concordant with previous studies that reported high SCE frequency in tumour cells obtained from the 
peripheral circulation in leukaemia patients as well as lymphoma, melanoma and colon cancer cell lines [21-
23].   
In support of the genomic instability suggested by their elevated SCE levels, γH2AX analysis also showed 
high levels on endogenous DNA DSBs among all the sarcoma cell lines compared with normal control cells 
(Figure 3).  These results are in keeping with those of Yu and colleagues who demonstrated elevated 
endogenous γH2AX foci among 17 cancer cell lines from the NCI-60 panel with 20 – 95% of cells showing 
foci [30].  In the same study, they also found that the number of foci seen correlated with the magnitude of 
karyotypic complexity of the cell lines evaluated, which supports our finding of high SCE levels among our 
cell lines that are derived from soft tissue sarcomas with very complex karyotypes.  It however does not 
account for the significant difference in the frequency of endogenous DNA DSBs observed between the two 
variants (ws and w1) of the leiomyosarcoma cell line, Shef-LMS 01 (Figure 3) even though they had very 
similar average SCE frequency and chromosome number (Figure 2, Table 1).    Endogenous γH2AX foci are 
believed to represent DNA DSBs resulting from replication fork collapse/stress during the cell cycle [10] while 
SCE represent their subsequent repair.   One possible explanation is that the cellular capacity for DNA repair 
by homologous recombination in these two tumour cell clones is finite resulting in their similar SCE levels 
despite the significant difference in the endogenous DSBs.   The remaining DNA damage in the ws variant 
may have been repaired via other cellular mechanisms such as non-homologous end-joining (NHEJ) which 
also is preceded by γH2AX formation [31, 32] or perhaps a relatively higher proportion of the cells were 
directed towards apoptosis.  This hypothesis warrants further investigation to evaluate both endogenous and 
induced (in response to IR and other genotoxic agents) apoptosis and NHEJ among these cell lines. 
Similarly, there was no correlation demonstrated between the frequency of SCE and endogenous H2AX foci 
among all the cell lines in this study when evaluated by Spearman’s test.  An illustrative example was the 
dedifferentiated liposarcoma cell line, Shef-DDLPS 02 that had high endogenous γH2AX foci but relatively 
low SCE counts (Figure 3).   A possible explanation is that despite the evidence of high frequency of DNA 
DSBs evidenced by the number of γH2AX foci, the tumour cells have a poor ability to perform subsequent 
DNA repair by homologous recombination resulting in paradoxically low SCE frequency.  This theory is 
supported by the good response (over 90% necrosis) to neoadjuvant radiotherapy that was seen on 
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histologic examination of the parent tumour for this cell line (data not shown).  Conversely, the U-2 OS cell 
line which had approximately double the SCE frequency observed in the other sarcoma cell lines had 
relatively few endogenous γH2AX foci (Figure 3), an overall picture that would suggest highly efficient DNA 
repair.  Given that U2OS is an osteosarcoma cell line and that this tumour subtype is known to be relatively 
resistant to radiotherapy, the results are not altogether surprising.  Again, further studies to evaluate the 
γH2AX foci, SCE counts and apoptotic response of these cell lines to ionising radiation (IR) would be useful 
to further elucidate the impact of endogenous genomic instability on treatment response in these sarcomas. 
Temporal changes in genomic instability with in vitro culture were assessed when SCE analysis of four 
primary cell lines was repeated after 4 months (Table 1).   The results showed that the SCE frequency 
remained around the same level with time in culture, suggesting that the magnitude of genetic instability 
remained fairly constant in these primary sarcoma cells.  According to the clonal evolution theory of cancer 
however, longer duration in culture permits the accumulation of further genomic aberrations with time and 
this is supported by an increase in the chromosome number observed in these cell lines with time and their 
acquisition of some new copy number abnormalities [24].  Perhaps therefore, an alternative DNA repair 
mechanism with less accuracy than homologous recombination and not represented by SCE analysis, is 
utilised by these tumour cells resulting in their continued accumulation of genomic aberrations.  Once again, 
further longitudinal studies with evaluation of various alternative DNA repair mechanisms are warranted.  
Conclusions 
This study is the first of its kind in sarcomas and confirms that genomic instability is indeed characteristic of 
these tumours.  It also highlights potential inter- and intra-tumour differences in DNA damage and/or 
responses as well as potential markers for the prediction of response to radiotherapy among these rare and 
heterogeneous tumours.  Overall the data, while not sufficient to make firm conclusions about their utility as 
biomarkers, suggests that there is still much to understand about the relationship between γH2AX and SCE 
in sarcomas.  Given that these tumours are so heterogeneous, it is likely that a number of explanations could 
exist including highly efficient homologous recombination, increased apoptosis or alternative DNA repair 
pathways.  Importantly, the stage is set for further studies that will improve our understanding of the 
mechanisms for genomic instability among sarcomas and how to utilise this for choosing appropriate 
treatments. 
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